Partial signaling by CD8+ T cells in response to antagonist ligands

Journal of Experimental Medicine

Volumn 184, Issue 1, 1996, Pages 149-157

  Reis E Sousa, Caetano ^a   Levine, Edward H ^a   Germain, Ronald N ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; LYMPHOCYTE SUBPOPULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMOCYTE;

AMINO ACID SEQUENCE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; INTERFERON TYPE II; LIGANDS; MICE; MOLECULAR SEQUENCE DATA; OVALBUMIN; PEPTIDES; PHOSPHOTYROSINE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SIGNAL TRANSDUCTION;

EID: 0009542458     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.1.149     Document Type: Article

References (39)

1. De Magistris, M.T.,J. Alexander, M. Coggeshall, A. Altman, F.C. Gaeta, H.M. Grey, and A. Sette. 1992. Antigen analogmajor histocompatibility complexes act as antagonists of the T cell receptor. Cell. 68:625-634.
2. Racioppi, L., F. Ronchese, L.A. Matis, and R.N. Germain. 1993. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J. Exp. Med. 177:1047-1060.
3. Jameson, S.C., F.R. Carbone, and M.J. Bevan. 1993. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J. Exp. Med. 177:1541-1550.
4. Klenerman, P., S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D. Lalloo, B. Koppe, W. Rosenberg, D. Boyd, A. Edwards et al. 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature (Lond.). 369:403-407.
5. Bertoletti, A., A. Sette, F.V. Chisari, A. Penna, M. Levrero, M. De Carli, F. Fiaccadori, and C. Ferrari. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature (Lond.). 369:407-410.
6. Ruppert, J., J. Alexander, K. Snoke, M. Coggeshall, E. Herbert, D. McKenzie, H.M. Grey, and A. Sette. 1993. Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events. Proc. Natl. Acad. Sci. USA. 90:2671-2675.
7. Sette, A., J. Alexander, J. Ruppert, K. Snoke, A. Franco, G. Ishioka, and H.M. Grey. 1994. Antigen analogs/MHC complexes as specific T cell receptor antagonists. Annu. Rev. Immunol. 12:413-431.
8. Hogquist, K.A., S.C. Jameson, W.R. Heath, J.L. Howard, M.J. Bevan, and F.R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell. 76:17-27.
9. Jameson, S.C., K.A. Hogquist, and M.J. Bevan. 1994. Specificity and flexibility in thymic selection. Nature (Lond.). 369: 750-752.
10. + T cells. Immunity. 3:79-86.
11. Williams, O., Y. Tanaka, M. Bix, M. Murdjeva, D.R. Littman, and D. Kioussis. 1996. Inhibition of thymocyte negative selection by T cell receptor antagonist peptides. Eur. J. Immunol. 26:532-538.
12. Evavold, B.D., and P.M. Allen. 1991. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science (Wash. DC). 252:1308-1310.
13. Evavold, B.D., J. Sloan-Lancaster, B.L. Hsu, and P.M. Allen. 1993. Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. J. Immunol. 150:3131-3140.
14. Sloan-Lancaster, J., B.D. Evavold, and P.M. Allen. 1993. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature (Lond.). 363:156-159.
15. Windhagen, A., C. Scholz, P. Höllsberg, H. Fukaura, A. Sette, and D.A. Hafler. 1995. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity. 2:373-380.
16. Sloan-Lancaster, J., A.S. Shaw, J.B. Rothbard, and P.M. Allen. 1994. Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy. Cell. 79:913-922.
17. Madrenas, J., R.L. Wange, J.L. Wang, N. Isakov, L.E. Samelson, and R.N. Germain. 1995. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science (Wash. DC). 267:515-518.
18. Falk, K., O. Rötzschke, S. Stevanovic, G. Jung, and H.G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (Lond.). 351:290-296.
19. Schumacher, T.N., M.L. De Bruijn, L.N. Vernie, W.M. Kast, C.J. Melief, J.J. Neefjes, and H.L. Ploegh. 1991. Peptide selection by MHC class I molecules. Nature (Lond.). 350: 703-706.
20. Matsumura, M., Y. Saito, M.R. Jackson, E.S. Song, and P.A. Peterson. 1992. In vitro peptide binding to soluble empty class I major histocompatibility complex molecules isolated from transfected Drosophila melanogaster cells. J. Biol. Chem. 267:23589-23595.
21. Reis e Sousa, C., and R.N. Germain. 1995. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J. Exp. Med. 182:841-851.
22. Ljunggren, H.G. and K. Kärre. 1985. Host resistance directed against H-2-deficient lymphoma variants. J. Exp. Med. 162:1745-1759.
23. Allen, H., D. Wraith, P. Pala, B. Askonas, and R.A. Flavell. 1984. Domain interactions of H-2 class I antigens alter cytotoxic T-cell recognition sites. Nature (Lond.). 309:279-281.
24. b-restricted ovalbumin peptide and an assessment of the predictive power of MHC-binding motifs. Eur. J. Immunol. 22:2663-2667.
25. Höllsberg, P., W.E. Weber, F. Dangond, V. Batra, A. Sette, and D.A. Hafler. 1995. Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I tax-specific CD8 T cells by an altered peptide ligand. Proc. Natl. Acad. Sci. USA. 92:4036-4040.
26. Weiss, A., and D.R. Littman. 1994. Signal transduction by lymphocyte antigen receptors. Cell. 76:263-274.
27. Chan, A.C., D.M. Desai, and A. Weiss. 1994. The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu. Rev. Immunol. 12:555-592.
28. Qian, D., I. Griswold-Prenner, M.R. Rosner, and F.W. Fitch. 1993. Multiple components of the T cell antigen receptor complex become tyrosine-phosphorylated upon activation. J. Biol. Chem. 268:4488-4493.
29. Snoke, K., J. Alexander, A. Franco, L. Smith, J.V. Brawley, P. Concannon, H.M. Grey, A. Sette, and P. Wentworth. 1993. The inhibition of different T cell lines specific for the same antigen with TCR antagonist peptides. J. Immunol. 151: 6815-6821.
30. Evavold, B.D., L.J. Sloan, and P.M. Allen. 1993. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol. Today. 14:602-609.
31. Jameson, S.C., and M.J. Bevan. 1995. T cell receptor antagonists and partial agonists. Immunity. 2:1-11.
32. Madrenas, J., and R.N. Germain. 1996. Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T cell activation. Scmin. Immunol. 8: 83-101.
33. Shi, J., and R.A. Miller. 1993. Differential tyrosine-specific protein phosphorylation in mouse T lymphocyte subsets. Effect of age. J. Immunol. 151:730-739.
34. + thymocytes by p56lck tyrosine kinase: basis for differential signaling by CD4 and CD8 in immature thymocytes expressing both coreceptor molecules. J. Exp. Med. 178:1701-1712.
35. Germain, R.N., E.H. Levine, and J. Madrenas. 1995. The T-cell receptor as a diverse signal transduction machine. Immmunologist. 3/4:113-121.
36. 35a.Madrenas, J., R.H. Schwartz, and R.N. Germain. 1996. IL-2 production, not the pattern of early TCR-dependent tyrosine phosphorylation, controls anergy induction by both agonists and partial agonists. Proc. Natl. Acad. Sci. USA. In press.
37. Tite, J.P., A. Sloan, and C.A. Janeway, Jr. 1986. The role of L3T4 in T cell activation: L3T4 may be both an la-binding protein and a receptor that transduces a negative signal. J. Mol. Cell Immunol. 2:179-190.
38. rds distinguishes positive and negative selection in thymocytes. EMBO (Eur. Mol. Biol. Organ.) J. 14:276-285.
39. Alberola-Ila, J., K.A. Forbush, R. Seger, E.G. Krebs, and R.M. Perlmutter. 1995. Selective requirement for MAP kinase activation in thymocyte differentiation. Nature (Lond.). 373:620-623.